PFM Health Sciences’s Centene CNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.63M | Sell |
263,486
-461,938
| -64% | -$18.9M | 0.79% | 41 |
|
|
2025
Q4 | $29.9M | Buy |
725,424
+151,064
| +26% | +$5.65M | 2.98% | 7 |
|
|
2025
Q3 | $20.5M | Buy |
+574,360
| New | +$17.3M | 1.58% | 18 |
|
|
2025
Q2 | – | Sell |
-135,398
| Closed | -$8.22M | – | 64 |
|
|
2025
Q1 | $8.22M | Sell |
135,398
-9,103
| -6% | -$550K | 0.6% | 36 |
|
|
2024
Q4 | $8.75M | Buy |
+144,501
| New | +$9.01M | 0.54% | 45 |
|
|
2024
Q3 | – | Sell |
-598,513
| Closed | -$39.7M | – | 77 |
|
|
2024
Q2 | $39.7M | Hold |
598,513
| – | – | 1.96% | 14 |
|
|
2024
Q1 | $47M | Buy |
598,513
+40,762
| +7% | +$3.15M | 2.21% | 10 |
|
|
2023
Q4 | $41.4M | Sell |
557,751
-232,117
| -29% | -$16.7M | 2.48% | 11 |
|
|
2023
Q3 | $54.4M | Sell |
789,868
-322,612
| -29% | -$21.5M | 2.56% | 9 |
|
|
2023
Q2 | $75M | Hold |
1,112,480
| – | – | 2.91% | 5 |
|
|
2023
Q1 | $70.3M | Hold |
1,112,480
| – | – | 3.11% | 6 |
|
|
2022
Q4 | $91.2M | Hold |
1,112,480
| – | – | 3.27% | 5 |
|
|
2022
Q3 | $86.6M | Hold |
1,112,480
| – | – | 3.13% | 5 |
|
|
2022
Q2 | $94.1M | Hold |
1,112,480
| – | – | 3.59% | 4 |
|
|
2022
Q1 | $93.7M | Hold |
1,112,480
| – | – | 3.5% | 5 |
|
|
2021
Q4 | $91.7M | Buy |
1,112,480
+127,609
| +13% | +$9.35M | 3.12% | 6 |
|
|
2021
Q3 | $61.4M | Sell |
984,871
-60,602
| -6% | -$4.05M | 1.8% | 20 |
|
|
2021
Q2 | $76.2M | Buy |
1,045,473
+511,806
| +96% | +$35.1M | 2.39% | 12 |
|
|
2021
Q1 | $34.1M | Buy |
533,667
+205,188
| +62% | +$12.7M | 1.04% | 34 |
|
|
2020
Q4 | $19.7M | Buy |
+328,479
| New | +$20.9M | 0.69% | 55 |
|
|
2020
Q2 | – | Sell |
-307,441
| Closed | -$18.3M | – | 82 |
|
|
2020
Q1 | $18.3M | Sell |
307,441
-511,788
| -62% | -$31.1M | 1.5% | 27 |
|
|
2019
Q4 | $51.5M | Buy |
+819,229
| New | +$44.4M | 2.45% | 15 |
|
|
2018
Q3 | – | Sell |
-1,302,436
| Closed | -$80.2M | – | 123 |
|
|
2018
Q2 | $80.2M | Buy |
+1,302,436
| New | +$75.1M | 1.26% | 23 |
|
|
2017
Q4 | – | Sell |
-1,768,650
| Closed | -$85.6M | – | 83 |
|
|
2017
Q3 | $85.6M | Buy |
+1,768,650
| New | +$76.1M | 1.68% | 17 |
|
|
2016
Q4 | – | Sell |
-407,514
| Closed | -$13.6M | – | 102 |
|
|
2016
Q3 | $13.6M | Buy |
+407,514
| New | +$14.2M | 0.4% | 65 |
|
|
2014
Q4 | – | Sell |
-302,676
| Closed | -$6.26M | – | 92 |
|
|
2014
Q3 | $6.26M | Buy |
+302,676
| New | +$5.83M | 0.14% | 58 |
|
Other funds holding CNC
VCM
VPM
PFM Health Sciences's CNC Position: Q1 2026 in Review
PFM Health Sciences reduced its Centene (CNC) stake by 64% in Q1 2026, selling an estimated $18.9M and leaving 263,486 shares worth $8.63M. The position accounts for 0.79% of the portfolio, ranked #41.
PFM Health Sciences first reported a position in CNC in Q3 2014 and has held it in 26 quarters since. The position peaked at $94.1M in Q2 2022. 862 funds tracked by Wall St. Rank hold CNC as of Q1 2026.
- PFM Health Sciences held 263,486 shares of Centene worth $8.63M as of Q1 2026.
- PFM Health Sciences sold 461,938 Centene shares in Q1 2026, an estimated $18.9M.
- Centene made up 0.79% of PFM Health Sciences's portfolio in Q1 2026, its #41 holding.
- PFM Health Sciences first reported a position in Centene in Q3 2014 and has held it in 26 quarters since.
- PFM Health Sciences's Centene position peaked at $94.1M in Q2 2022.
- 862 funds tracked by Wall St. Rank held Centene as of Q1 2026.
Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.